- Evolving market conditions and expected future demand for COVID-19 vaccines.
- Macroeconomic environment challenges.
Clover Biopharmaceuticals, Ltd. 三葉草生物製藥有限公司
Greenhouse gas emissions & sustainability report data
Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 18.1K tCO2e/year |
| 2022 | 19.4K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Delivering AdimFlu-S (QIS) sales target
📅 Medium-term
- Accelerate the development of RSV vaccine candidate
- License in a mid- to late-stage vaccine product to diversify respiratory products and strengthen commercialization potential.